ReviewOncogene2005

Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.

Ali R Jazirehi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.